Treatment of Ascites
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,364,277 | Treatment of Ascites In force · High confidence UsedRemaining | Biovie, Inc. | In force | High confidence | ||
| US 9,655,945 | Treatment of Ascites Lapsed May 23, 2021 on the fee record High confidence | Universita Degli Studi Di Padova | Lapsed May 23, 2021 on the fee record | High confidence | ||
| Application 15/491,613 | Treatment of Ascites Abandoned Abandoned May 10, 2019 | Universita Degli Studi Di Padova | Abandoned | Abandoned May 10, 2019 | ||
| Application 17/831,556 | Treatment of Ascites Abandoned Abandoned May 16, 2024 | Universita Degli Studi Di Padova | Abandoned | Abandoned May 16, 2024 | ||
| Application 18/420,332 | Treatment of Ascites Abandoned Abandoned Sep 19, 2025 | Universita Degli Studi Di Padova | Abandoned | Abandoned Sep 19, 2025 | ||
| Application 19/236,445 | Treatment of Ascites Pending Not granted | Universita Degli Studi Di Padova | Pending | Not granted |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Biovie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.